Note 16 - Net Loss Per Share - Schedule of Antidilutive Securities (Details) - shares	12 Months Ended
Dec. 31, 2024	Dec. 31, 2023
Antidilutive securities (in shares)	5,284,099	5,090,911
Warrant [Member]
Antidilutive securities (in shares)	898,622	1,113,622
Share-Based Payment Arrangement, Option [Member]
Antidilutive securities (in shares)	4,385,477	3,977,289

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 260
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (c)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482662/260-10-50-1

Name:	us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration